Trial · NCT02909504
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | NLRP3 | 30.73 | Standard Deviation 5.66 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | NLRP3 | 26.00 | Standard Deviation 7.25 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | PDEB4 | 28.15 | Standard Deviation 9.12 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | PDEB4 | 27.31 | Standard Deviation 5.78 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | BAK | 11.16 | Standard Deviation 2.08 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | BAK | 11.50 | Standard Deviation 2.88 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | p-Fyn Yes | 12.49 | Standard Deviation 4.46 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | p-Fyn Yes | 13.33 | Standard Deviation 6.44 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | HMGB1 | 23.18 | Standard Deviation 8.69 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | HMGB1 | 22.61 | Standard Deviation 6.58 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | IRS2 | 25.29 | Standard Deviation 5.64 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | IRS2 | 24.06 | Standard Deviation 8.71 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | p-CREB | 30.78 | Standard Deviation 4.34 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | p-CREB | 30.46 | Standard Deviation 6.55 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | PPAR g | 21.90 | Standard Deviation 4.31 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | PPAR g | 21.13 | Standard Deviation 5.62 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | TNFAIP3 | 33.74 | Standard Deviation 6.16 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | TNFAIP3 | 31.17 | Standard Deviation 6.64 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Non Responders | TPH1 | 7.13 | Standard Deviation 1.04 | fluorescence intensity |
| Change in Expression of ~45 Molecules in Blood Cells of Patients With Bipolar I or II Disorder Being Treated With Lithium | Lithium Responders | TPH1 | 7.23 | Standard Deviation 2.47 | fluorescence intensity |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02909504/results